Clinical Trials Directory

Trials / Unknown

UnknownNCT03907306

Cold Argon Plasma (CAP) Application in the Wound Treatment After Open Hemorrhoidectomy

Cold Argon Plasma Application in the Wound Treatment After Open Hemorrhoidectomy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
State Scientific Centre of Coloproctology, Russian Federation · Other Government
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

This is single-center, prospective, randomized study

Detailed description

This study will include patients with 3-4 stage hemorrhoids. They will undergo an operation of open hemorrhoidectomy. Patients will be divided into a study group and a control group. Study group patients during a post-operation period except a standard treatment (antiseptic solutions and antibacterial and wound healing ointments) of a post-operation wound will be treated with cold argon plasma. Control group patients will be treated with a standard treatment. Wound healing speed will be researched.

Conditions

Interventions

TypeNameDescription
PROCEDUREWound healingThe measurement of a wound area is committed on the 2nd, 8th, 14th, 21nd and 30th day after operation. By means of the mathematical formulas the wound healing speed will be defined. The wound process will be researched with the help of cytological method. The wound prints will be taken on the 2nd, 8th, 14th, 21nd and 30th day after operation. Microbiological research of a wound will be held on the 2nd, 8th, 14th, 21nd and 30th day after operation (in study groups before and after the usage of CAP, in control groups once). The pain assessment will be measured by a visual analogue scale on the 2nd, 3rd,4th, 5th, 6th, 7th, 8th, 14th, 21nd and 30th day after operation. The life quality will be researched by means of Health Status Survey on the 8th and 30th day before operation.

Timeline

Start date
2018-09-01
Primary completion
2019-12-31
Completion
2021-03-31
First posted
2019-04-08
Last updated
2019-04-08

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT03907306. Inclusion in this directory is not an endorsement.